Skip to the page

Data / Drug companies / Gastrointestinal Motility Inhibitor

Gastrointestinal Motility Inhibitor drugs: 3 drugs from 7 companies in the FDA NDC directory

Gastrointestinal Motility Inhibitor is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 12 products in this class from 7 companies, covering 3 drugs by generic name. The main marketing category is new drug applications (NDA), and the newest product started marketing on August 19, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 7Companies
  • 12Products
  • 3Drugs by generic name

Drugs in the Gastrointestinal Motility Inhibitor class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Glucagon69
Glucagon injection, solution41
Glucagon injection11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Xeris Pharmaceuticals, Inc.4injection, solutionNew drug applications (NDA)October 11, 2021
Amphastar Pharmaceuticals, Inc.2powderNew drug applications (NDA)July 24, 2019
Fresenius Kabi USA, LLC2injection, powder, lyophilized, for solutionNew drug applications (NDA)May 8, 2015
American Regent, Inc.1injection, solutionNew drug applications (NDA)August 19, 2025
Healthsource of New England LLC1liquidUnapproved homeopathic productsApril 11, 2018
Professional Complementary Health Formulas1liquidUnapproved homeopathic productsAugust 15, 1984
Sportpharm LLC1powderNew drug applications (NDA)July 24, 2019

Dosage forms

Dosage formProductsShare
Injection, solution541.7%
Powder325%
Liquid216.7%
Injection, powder, lyophilized, for solution216.7%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.